BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38626703)

  • 21. Signaling Pathways that Regulate Macropinocytosis in Mammalian Cells.
    Palm W
    Subcell Biochem; 2022; 98():143-167. PubMed ID: 35378707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macropinocytosis, mTORC1 and cellular growth control.
    Yoshida S; Pacitto R; Inoki K; Swanson J
    Cell Mol Life Sci; 2018 Apr; 75(7):1227-1239. PubMed ID: 29119228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phellodendrine chloride suppresses proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis.
    Thu PM; Zheng ZG; Zhou YP; Wang YY; Zhang X; Jing D; Cheng HM; Li J; Li P; Xu X
    Eur J Pharmacol; 2019 May; 850():23-34. PubMed ID: 30716311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uses and abuses of macropinocytosis.
    Bloomfield G; Kay RR
    J Cell Sci; 2016 Jul; 129(14):2697-705. PubMed ID: 27352861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macropinocytosis: the big drinker behind cancer cell self-consumption.
    Su H; Yang F; Sun B; Karin M
    Autophagy; 2021 May; 17(5):1290-1291. PubMed ID: 33879021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macropinocytosis: A Metabolic Adaptation to Nutrient Stress in Cancer.
    Recouvreux MV; Commisso C
    Front Endocrinol (Lausanne); 2017; 8():261. PubMed ID: 29085336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligopeptide transporter Slc15A modulates macropinocytosis in Dictyostelium by maintaining intracellular nutrient status.
    Zhang Y; Tu H; Hao Y; Li D; Yang Y; Yuan Y; Guo Z; Li L; Wang H; Cai H
    J Cell Sci; 2022 Apr; 135(7):. PubMed ID: 35267018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCL12-induced macropinocytosis modulates two distinct pathways to activate mTORC1 in macrophages.
    Pacitto R; Gaeta I; Swanson JA; Yoshida S
    J Leukoc Biol; 2017 Mar; 101(3):683-692. PubMed ID: 28250113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells.
    Commisso C; Davidson SM; Soydaner-Azeloglu RG; Parker SJ; Kamphorst JJ; Hackett S; Grabocka E; Nofal M; Drebin JA; Thompson CB; Rabinowitz JD; Metallo CM; Vander Heiden MG; Bar-Sagi D
    Nature; 2013 May; 497(7451):633-7. PubMed ID: 23665962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wnt canonical pathway activates macropinocytosis and lysosomal degradation of extracellular proteins.
    Tejeda-Muñoz N; Albrecht LV; Bui MH; De Robertis EM
    Proc Natl Acad Sci U S A; 2019 May; 116(21):10402-10411. PubMed ID: 31061124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macropinocytosis: mechanisms and regulation.
    Salloum G; Bresnick AR; Backer JM
    Biochem J; 2023 Mar; 480(5):335-362. PubMed ID: 36920093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unravelling the Mechanism of TrkA-Induced Cell Death by Macropinocytosis in Medulloblastoma Daoy Cells.
    Li C; MacDonald JI; Talebian A; Leuenberger J; Seah C; Pasternak SH; Michnick SW; Meakin SO
    Mol Cell Biol; 2016 Oct; 36(20):2596-611. PubMed ID: 27503856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-content, full genome siRNA screen for regulators of oncogenic HRAS-driven macropinocytosis.
    Fennell M; Commisso C; Ramirez C; Garippa R; Bar-Sagi D
    Assay Drug Dev Technol; 2015 Sep; 13(7):347-55. PubMed ID: 26267765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macropinosomes as units of signal transduction.
    Swanson JA; Yoshida S
    Philos Trans R Soc Lond B Biol Sci; 2019 Feb; 374(1765):20180157. PubMed ID: 30967006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ATM inhibition drives metabolic adaptation via induction of macropinocytosis.
    Huang Z; Chen CW; Buj R; Tangudu NK; Fang RS; Leon KE; Dahl ES; Varner EL; von Krusenstiern E; Cole AR; Snyder NW; Aird KM
    J Cell Biol; 2023 Jan; 222(1):. PubMed ID: 36399181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitation of Macropinocytosis in Cancer Cells.
    Galenkamp KMO; Alas B; Commisso C
    Methods Mol Biol; 2019; 1928():113-123. PubMed ID: 30725454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual blockade of macropinocytosis and asparagine bioavailability shows synergistic anti-tumor effects on KRAS-mutant colorectal cancer.
    Hanada K; Kawada K; Nishikawa G; Toda K; Maekawa H; Nishikawa Y; Masui H; Hirata W; Okamoto M; Kiyasu Y; Honma S; Ogawa R; Mizuno R; Itatani Y; Miyoshi H; Sasazuki T; Shirasawa S; Taketo MM; Obama K; Sakai Y
    Cancer Lett; 2021 Dec; 522():129-141. PubMed ID: 34543685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of nutrient limitation in cancer.
    Sullivan MR; Vander Heiden MG
    Crit Rev Biochem Mol Biol; 2019 Jun; 54(3):193-207. PubMed ID: 31162937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drinking problems: mechanisms of macropinosome formation and maturation.
    Buckley CM; King JS
    FEBS J; 2017 Nov; 284(22):3778-3790. PubMed ID: 28544479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploiting macropinocytosis for drug delivery into KRAS mutant cancer.
    Liu H; Qian F
    Theranostics; 2022; 12(3):1321-1332. PubMed ID: 35154489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.